References in periodicals archive ?
The Joint Secretary (C-II) congratulated the newly elected Chairman on behalf of the Honourable Speaker and Secretary, National Assembly Secretariat.
Pharmaceutical company Egalet Corporation (Nasdaq:EGLT) reported on Friday the receipt of US Food and Drug Administration (FDA) tentative approval for an expanded label for ARYMO ER extended-release (ER) tablets C-II for the management of chronic pain.
This US FDA tentative approval has been awarded for an expanded label for ARYMO ER (morphine sulfate) extended-release (ER) tablets C-II for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Similarly, the sources said for Phase-II 1,419 employees got registered themselves for Category-one, 5,484 applicants for C-II, 12,269 for C-III, 8,831 for C-lV and 18,641 applications were received for C-V.
Results: Median nerve latency was significantly higher, amplitude and velocity were significantly lower in C-I and C-II groups as compared to controls (p less than 0.05) but the difference in C-I and C-II group was insignificant (p greater than 0.05).
From the above discussion we felt that the probable diagnosis of the child would be Familial Chylomicronemia / Hypertriglyceridemia which could be either due to LPL deficiency or Apo C-II deficiency.
Oxycodone HCl is the generic version of Purdue's OxyContin C-II tablets, a narcotic analgesic treatment of moderate to severe pain for patients needing round-the-clock analgesic for an extended period.
In general, A-II (55.5%), B-I (3.6%), B-Ia (9.5%), B-II (8.3%), and C-II (22.5%) were the five major [beta]-amylase phenotypes in cultivated barley.
Pharmaceutical company Egalet (NasdaqGM:EGLT) reported on Monday the receipt of approval from the US Food and Drug Administration (FDA) for ARYMO ER tablets C-II for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Acronyms browser ?
Full browser ?
- c-has/bas p21 protein
- c-Jun kinase 2
- c-Jun N-terminal kinase 1
- c-Jun N-Terminal Kinase 1/Stress-Activated Protein Kinase
- c-Jun N-terminal kinase 2
- c-Jun N-terminal kinase 3
- c-Jun N-terminal kinase kinase 1
- c-Jun N-terminal kinase kinase 2
- c-Jun NH2-terminal kinase-associated leucine zipper protein
- c-Jun NH2-Terminal Kinase/Stress-Activated Protein Kinase
- C-Jun-amino-terminal kinase-interacting protein 4
- c-Kirsten-ras protein
- c-Kit ligand
- C-labeled door